Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Tarantula Venom Peptide Shows Promise as a Drug

15.07.2004


A tarantula venom peptide, GsMTx4, known to affect many organs, can be manipulated to withstand destruction in the stomach, making it a promising candidate for drugs that could treat cardiac arrhythmias, muscular dystrophy and many other conditions, University at Buffalo biophysicists have shown.



Moreover, the peptide, which is amphiphilic -- meaning fat-soluble on one side and water-soluble on the other, much like a detergent -- affects mechanically sensitive ion channels in membranes in a manner totally different than the standard "lock-and-key" binding mechanism.

Results of the research appear in the July 8 issue of the journal Nature.


The peptide is the only agent known to specifically block stretch-sensitive channels. Unlike other membrane channels that are sensitive to electrical potential or the binding of hormones and neurotransmitters, stretch-sensitive channels are activated by changes in membrane tension.

"Stretch-sensitive channels can play a key role in many normal tissue functions," said Tom Suchyna, Ph.D., research associate in the UB Center for Single Molecule Studies and first author on the paper. "These channels are involved in hollow-organ filling such as the bladder, in heart and circulatory-system responses to changes in blood pressure, proprioception -- knowing where your limbs and head are in space and time -- and fluid balance.

"They also are involved in abnormal tissue functions such as cardiac arrhythmias, congestive heart failure, elevated calcium levels in muscular dystrophy, and angiogenesis-supported tumor growth."

Earlier research by the UB group had shown that the novel peptide inhibits stretch-sensitive channels, but the researchers didn’t know how. To gain more information on the peptide’s possible receptor, Phillip Gottlieb, Ph.D., a co-investigator from the UB Department of Physiology and Biophysics and the Hughes Center for Single Molecule Studies, created a mirror image of the molecule, referred to as "right-handed," to observe the peptide-membrane interaction.

Since almost all proteins in nature on "left-handed," right-handed proteins won’t fit into a left-handed receptor, even if they have the same amino acid sequence. "It’s like putting your right foot into your left shoe," said Suchyna.

In this case, however, they found that both proteins inhibited stretch-sensitive channels. "If the right handed GsMTx4 works as well as the left-handed, it must be interacting with the stretch-activated channel by changing the tension that the channel senses in the membrane, rather than locking onto the channel," he said. "This leads us to believe that there is something unique about the membrane that surrounds stretch-sensitive channels, and that this special membrane environment attracts GsMTx4. That would explain why this peptide blocks only this type of channel."

In addition to providing valuable information on how the peptide works, the finding that both versions blocked the channels makes the peptide an attractive drug candidate. "This was an awesome tool to find," said Fred Sachs, Ph.D., UB professor of biophysics in the Hughes Center for Single Molecule Studies and senior author on the study.

"Peptides usually don’t make good drug candidates. They can’t be given by mouth because the stomach enzymes digest them, and they can cause an immune response. But because this peptide works in its right-handed form, and the normal left-handed digestive enzymes and left-handed antibodies don’t recognize it, oral administration is a definite possibility. It may be more than a lead compound for drug development. It may work just as it is.

"If this prognosis proves correct," said Sachs, "the peptide could be an effective treatment for atrial fibrillation, incontinence, muscular dystrophy, high blood pressure and other conditions governed by stress-sensitive channels."

Suchyna said the next steps will be to investigate the environment surrounding the channels, to study the role of stretch-activated channels in cardiac arrhythmias and to mutate the peptide to make it specific for different tissues.

Studies of these peptides on a model ion channel called gramicidin, reconstituted in artificial lipid membranes, were carried out by Sonya E. Tape, a graduate student, and Olaf S. Anderson, M.D., both from the Weill Medical College of Cornell University, and Roger E. Koeppe II, Ph.D., from the University of Arkansas.

The research was supported by grants from the National Institutes of Health.

The University at Buffalo is a premier research-intensive public university, the largest and most comprehensive campus in the State University of New York. UB’s more than 27,000 students pursue their academic interests through more than 300 undergraduate, graduate and professional degree programs.

| newswise
Further information:
http://www.buffalo.edu

More articles from Life Sciences:

nachricht Symbiotic bacteria: from hitchhiker to beetle bodyguard
28.04.2017 | Johannes Gutenberg-Universität Mainz

nachricht Nose2Brain – Better Therapy for Multiple Sclerosis
28.04.2017 | Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>